This inventor holds 4 USPTO granted patents. Top assignee: American Home Products Corporation. Active years: 1976-1983.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976-1983
Title: The Innovations of William Dvonch
Introduction
William Dvonch is a notable inventor based in Radnor, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic effects. With a total of 4 patents to his name, Dvonch's work has the potential to impact medical treatments significantly.
Latest Patents
Dvonch's latest patents include innovative compounds such as enkephalin degrading enzyme inhibitors. These compounds inhibit the brain enzyme degradation of enkephalins and exhibit their own analgesic effect. The formula for these compounds includes various components, where R.sub.1 is hydrogen or lower alkyl, and X can be hydrogen, hydroxy, halo, nitro, amino, or lower alkoxy. Another significant patent is for antitumor derivatives of periodate-oxidized cytidine. This patent describes a reaction that produces a product with activity against lymphocytic leukemia P388 in mice, showcasing Dvonch's commitment to advancing cancer treatment.
Career Highlights
Dvonch has worked with American Home Products Corporation, where he has been able to apply his innovative ideas in a corporate setting. His work has contributed to the development of new pharmaceutical products that address critical health issues.
Collaborations
Throughout his career, Dvonch has collaborated with notable colleagues such as Harvey E Alburn and Dimitrios Sarantakis. These collaborations have likely enhanced the scope and impact of his inventions.
Conclusion
William Dvonch's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile